Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies130

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies42

Views

Views
December 20250
January 20261
February 20260
March 20265
April 20263
May 202621
June 202612
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States24
Netherlands3
Colombia2
Ecuador2
Argentina2
Germany1
Egypt1
Spain1
France1
United Kingdom1
 

Top cities views

Views
Groningen3
Boston3
Ambato1
Ankara1
Bedford1
Berlin1
Bogotá1
Brenes1
Brentwood1
Cairo1